5 332
订阅者
+324 小时
+287 天
+9630 天
帖子存档
5 333
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with
chronic kidney disease: a clinical practice guidelin
5 333
Four functional changes are desirable as outcomes for MASH therapy:
✅Anti-inflammatory
✅Metabolic
✅Anti-fibrotic
✅Calorie intake reducing
5 333
Pancreatic cysts can be grouped into different types:
1️⃣ Pseudocysts
2️⃣ Common cystic neoplasms: IPMN, SCN, and MCN
3️⃣ Uncommon cystic neoplasms: SPEN
4️⃣ Tumors with cystic degeneration: adenocarcinoma and neuroendocrine tumor
5 333
Action of THRβ, PPARα and glucagon agonists on hepatocytes in metabolic dysfunction associated steatohepatitis ( MASH)
5 333
Flowchart showing classification and subclassification of steatotic liver disease.
5 333
+2
Algorithm for Diagnosis and Management of Esophageal Dysmotility Disorders
5 333
Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada
